Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials
Annals of Pharmacotherapy · 2024
DOI: 10.1177/10600280231211304 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of Pharmacotherapy, 2024. Verfasst von Marina Sánchez-Rico und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Fluvoxamine, COVID-19 Drug Treatment, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Marina Sánchez-Rico
Zitieren
APA
Sánchez-Rico, M., Rezaei, K., Lenze, E. J., Limosin, F., & Hoertel, N. (2024). Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280231211304
Vancouver
Sánchez-Rico M, Rezaei K, Lenze EJ, Limosin F, Hoertel N. Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials. Annals of Pharmacotherapy. 2024. doi:10.1177/10600280231211304
BibTeX
@article{SnchezRico2024,
author = {Sánchez-Rico, Marina and Rezaei, Katayoun and Lenze, Eric J and Limosin, Frédéric and Hoertel, Nicolas},
title = {Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials},
journal = {Annals of Pharmacotherapy},
year = {2024},
doi = {10.1177/10600280231211304}
}
EUVIMED